Cilengitide
- Generic Name
- Cilengitide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H40N8O7
- CAS Number
- 188968-51-6
- Unique Ingredient Identifier
- 4EDF46E4GI
- Background
Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
A Clinician's Guide to Treating Patients With Glioblastoma
Glioblastoma, a highly aggressive brain tumor, is treated with maximal safe resection, radiotherapy, and temozolomide. Molecular profiling, including IDH mutation and MGMT promoter methylation, aids in prognosis. Treatment varies by age, with younger patients receiving more aggressive therapy. Recurrent disease lacks effective treatments, emphasizing clinical trials. Ongoing research explores immunotherapy and targeted therapies.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath